Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?

E-ISSN： 1873-5592|11|1|122-135

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.1, 2010-01, pp. : 122-135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adipokines in the treatment of diabetes mellitus and obesity

By Catalán Victoria Gómez-Ambrosi Javier Rodríguez Amaia Salvador Javier Frühbeck Gema

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. : 239-254

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Obesity: Should We Target the Individual or Society?

Current Pharmaceutical Design, Vol. 9, Iss. 15, 2003-06 ,pp. : 1151-1163

Bentham Science Publishers

Access to resources Recommend Favorite

Obesity-related physiological changes and their pharmacokinetic consequences

By Cho Sung-Joon

Journal of Pharmaceutical Investigation, Vol. 43, Iss. 3, 2013-06 ,pp. : 161-169

Springer Publishing Company

Access to resources Recommend Favorite

Adiponectin and Insulin Resistance in Obesity-related Diseases

By Ebinç H Ozkurt ZN Ebinç FA Yilmaz M Caglayan O

The Journal of International Medical Research, Vol. 36, Iss. 1, 2008-01 ,pp. : 71-79

Field House Publishing

Access to resources Recommend Favorite

Adiponectin as a Target in Obesity-related Inflammatory State

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 2, 2015-06 ,pp. : 145-150

Bentham Science Publishers

Access to resources Recommend Favorite